NetworkNewsBreaks Archive - Page 1400 of 2081

TuesdayMar 24, 2020 11:24 am

NetworkNewsBreaks – The Motley Fool Evaluates Four Major US Airlines Amid Bailout Request

A recent editorial by Brian Stoffel on The Motley Fool titled, ‘Is This the End of Stock Buybacks?’ discusses the drastic cuts made by four major U.S. airlines American Airlines Group, Inc. (NASDAQ: AAL), Delta Air Lines, Inc. (NYSE: DAL), United Airlines Holdings, Inc. (NASDAQ: UAL), and Southwest Airlines Company (NYSE: LUV). The article responds to the airlines’ request for Government support, originally asking for a $50 billion bailout which was later revised to $29 billion. Among other highlights, it also includes an in-depth look at these airlines’ free cash flow (“FCF”), share repurchases and stock-based value (payments) per year…

TuesdayMar 24, 2020 10:20 am

NetworkNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) Announces Strategic Board Appointments of Three Biotechnology and Healthcare Industry Leaders

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, today announced the appointment of three new members to its Board of Directors. The new appointments, which include Brent Longnecker, CEO of Longnecker & Associates, Jose A. Moreno Toscano, CEO of LFB USA Inc, and William R. (“Will”) Wilson, Jr., chairman, president and CEO of Wilson Land & Cattle Co., are designed to strengthen Genprex as it executes on its key clinical programs, continues to build its pipeline, and evaluates future license or corporate partnership agreements. “We are honored to have Brent,…

TuesdayMar 24, 2020 10:05 am

NetworkNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) to Participate in Life Sciences Investor Forum’s Virtual Conference

Life Sciences Investor Forum today announced the schedule for its inaugural event for both public and private companies, investors and worldwide industry professionals. The one-day event is kicking off on Thursday, March 26 with the first live webcast at 9:30 AM ET. Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP), a global innovator in drug delivery platforms, is scheduled to provide a presentation at 12:00 PM ET on March 26. Per the release, pre-registration is recommended for investors and it is encouraged that they run the online system check to expedite participation and receive event updates. There is no cost to view…

MondayMar 23, 2020 2:15 pm

NetworkNewsBreaks – Veritas Health Solutions Announces Details of Program, Provides Telemedicine Solution to Coronavirus Healthcare Crisis

Veritas Health Solutions, a brand of InService Marketing Group which offers discount plans managed and administered by VantageAmerica Solutions, today announced the details of its telemedicine program. According to the update, the Veritas Telemedicine program, positioned to be the most comprehensive telemedicine offering available, includes 24/7 call-a-doc, $10,000 life insurance, TruScript prescription plan, Trupoint Tax Service, TravNow and discounts on prescriptions, vision services, hearing services and more. “Our company has been working in the medical profession for the last 25 years providing services for health care services such as telemedicine, remote patient monitoring, medical transportation, clinical testing, medical specialty care,”…

MondayMar 23, 2020 1:50 pm

NetworkNewsBreaks – Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) Commences Delivery of $3M to $5M of Rugged and In-Vehicle Push-to-Talk Devices

Siyata Mobile (TSX.V: SIM) (OTCQX: SYATF) today announced that it has commenced delivery on its large government tender for up to 15,000 push-to-talk devices, previously announced on December 02, 2019. According to the update, the majority of the order is anticipated to be delivered in Q1 and Q2 and the tender is valued between $3-million to $5-million, depending on the total units and mix between rugged handsets and in-vehicle devices. “Make no mistake, push-to-talk devices are mission critical solutions for public safety workers on the first line of defense; they are supported by dedicated cellular networks to improve communication, while…

MondayMar 23, 2020 1:25 pm

NetworkNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) Expands Leadership Team with Appointment of Accomplished Life Science Executives

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, today announced the appointment of Catherine M. Vaczy as executive vice president and chief strategy officer and Michael T. Redman as executive vice president and chief operating officer. These appointments follow on the heels of Genprex’s Fast Track Designation for its lead drug candidate, its newly licensed gene therapy for diabetes, and over $26 million capital raise that will support funding of its clinical programs. “We are delighted to welcome Catherine and Michael to our executive leadership team. They join us at…

MondayMar 23, 2020 12:55 pm

NetworkNewsBreaks – Champignon Brands Inc. (CSE: SHRM) CEO Shares Strategic Goals in Exclusive Audio Interview

Champignon Brands (CSE: SHRM), a wellness company specializing in medicinal mushroom and mushroom-infused products, today announced the broadcast of its audio interview with NetworkNewsAudio (“NNA”), one of 40+ brands in the InvestorBrandNetwork (“IBN”). In the interview, Champignon Brands CEO Gareth Birdsall joins NNW’s Stuart Smith to delve into the company’s strategic plan to expand its portfolio and become a preeminent player in the emerging psychedelic medicine arena. “We’ve achieved some pretty impressive sales from around the globe, revamped our e-commerce website, as well as commenced certain research and development initiatives,” Birdsall said, noting Champignon recently completed an initial public offering…

MondayMar 23, 2020 12:28 pm

NetworkNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Secures $3.5 Million in Private Placement

Predictive Oncology (NASDAQ: POAI), a data and artificial intelligence (“AI”) driven discovery services company that provides predictive models of tumor drug response to improve clinical outcomes for patients, today announced its March 19, 2020, closing on its previously announced private offering of common stock and warrants resulting in gross proceeds of $3,498,612 to the Company. Per the offering, the Company sold and issued 1,650,166 shares of common stock (or common stock equivalents) and issued Series A warrants to acquire 1,650,166 shares of Common Stock at $1.88 per share, exercisable immediately and terminating five and one-half years after the date of…

MondayMar 23, 2020 11:51 am

NetworkNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Announces Expansion of Pharmaceutical Division to Include Lipophilic Antiviral Active Molecules for COVID-19 Treatment

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP), a global innovator in drug delivery platforms, today announced expansion of the scope and activities of its 100%-owned subsidiary Lexaria Pharmaceutical Corp. According to the update, Lexaria Pharmaceutical will investigate how the company’s patented DehydraTECH(TM) drug delivery technology could enhance delivery and effectiveness of certain antiviral drugs in the fight against coronavirus disease COVID-19. Lexaria intends to expand collaboration with leading laboratories across North America and internationally as soon as possible. To view the full press release, visit http://nnw.fm/sX25h About Lexaria Lexaria Bioscience Corp. is a global innovator in drug delivery platforms. Its…

MondayMar 23, 2020 11:22 am

NetworkNewsBreaks – Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) Announces Financial Results for Q4 and Fiscal Year 2019

Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT), a producer, developer and operator of augmented reality ("AR") interactive entertainment games, toys and educational materials in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2019. "We are pleased to report another quarter of healthy revenue growth and increased profitability in the fourth quarter, concluding a strong 2019 that saw Blue Hat become a U.S. listed public company while making progress in sales, business development and research and development," Blue Hat CEO Xiaodong Chen said in the news release. "A particular highlight during the…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsBreaks